Marksans Pharma’s arm secures marketing authorization for three products

21 Aug 2024 Evaluate

Marksans Pharma’s wholly owned subsidiary -- Relonchem has received Marketing Authorization from UKMHRA for the three products. These products are Fluoxetine 10mg Capsules, Fluoxetine 30mg Capsules and Fluoxetine 60mg Capsules. 

Earlier, the USFDA had issued an Establishment Inspection Report (EIR) for the manufacturing facility of Marksans Pharma located at Verna Industrial estate, Verna, Goa, India.  

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.


Marksans Pharma Share Price

291.60 2.10 (0.73%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.